1 – 10 of 394
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2024
-
Total adiponectin in indigenous Melanesians on Kitava
(2024)
In American Journal of Human Biology
36(10).
- Contribution to journal › Article
-
The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice
(2024)
In Peptides
171.
- Contribution to journal › Article
- 2023
-
Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
(2023)
In Biomedicines
11(2).
- Contribution to journal › Article
-
Gut hormone-based pharmacology : novel formulations and future possibilities for metabolic disease therapy
(2023)
In Diabetologia
66(10).
p.1796-1808
- Contribution to journal › Scientific review
-
Paradigm Shift in the Management of Metabolic Diseases—Next-Generation Incretin Therapy
(2023)
In Endocrinology (United States)
164(12).
- Contribution to journal › Scientific review
- 2022
-
Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients
(2022)
In Nutrients
14(2).
- Contribution to journal › Article
-
Assessing the Effect of Incretin Hormones and Other Insulin Secretagogues on Pancreatic Beta-Cell Function : Review on Mathematical Modelling Approaches
(2022)
In Biomedicines
10(5).
- Contribution to journal › Scientific review
-
The Glucose Sensitivity of Insulin Secretion-Lessons from In Vivo and In Vitro Studies in Mice
(2022)
In Biomolecules
12(7).
- Contribution to journal › Article
-
Glucose-dependent insulinotropic polypeptide secretion after oral macronutrient ingestion : The human literature revisited and a systematic study in model experiments in mice
(2022)
In Journal of Diabetes Investigation
13(10).
p.1655-1665
- Contribution to journal › Article
- 2021
-
The mediation by GLP-1 receptors of glucagon-induced insulin secretion revisited in GLP-1 receptor knockout mice
(2021)
In Peptides
135.
- Contribution to journal › Article